Advertisement

Hospital based preliminary study on osteoporosis in postmenopausal women

  • Indumati V. 
  • Vidya S. Patil
  • Rama Jailkhani
Article

Abstract

The awareness of osteoporosis has grown world wide in recent years. This silently progressing metabolic bone disease is widely prevalent in India, and osteoporotic fractures are a common cause of morbidity and mortality in adult Indian men and women. Rapid bone loss occurs in postmenopausal women due to hormonal factors which lead to increased risk of fractures. Biochemical markers of bone metabolism are used to assess skeletal turnover. A cross-sectional study of 150 pre- and post menopausal women was carried out at S.D.M College of Medical Sciences and Hospital, Dharwad, during the period of May 2005 to September 2005. The study group consisted of 75 Premenopausal women in the age group of 25–45 years and 75 Postmenopausal women in the age group of 46–65 years. Bone formation markers (Total Calcium, lonised calcium, Phosphorus, Alkaline phosphatase), and bone resorption markers (Urinary Hydroxyproline) were analysed in pre and post menopausal women. Bone formation markers, Total and lonised calcium were significantly decreased (p<0.001) and Alkaline phosphatase was significantly increased (p<0.001) in postmenopausal women compared to premenopausal women. Bone resorption markers, Urinary hydroxyproline excretion was significantly increased (p<0.001) in postmenopausal women. The results from this study suggest that simple, easy, common biochemical markers can still be used to assess the bone turnover in postmenopausal women and hence their risk of developing osteoporosis and fractures.

Key Words

Postmenopausal osteoporosis Urinary Hydroxyproline Alkaline phosphatase 

References

  1. 1.
    Simsek B, Karacaer O, Karaca I. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview. Chin Med J 2004; 117(2): 291–95PubMedGoogle Scholar
  2. 2.
    Vipla Puri. Biochemical Markers: Diagnostic Considerations and Clinical Applications for Osteoporosis Assessment. Bombay Hospital Journal. 2003: 45(2). http://www.bhj.org/journal/2003_4502_april/biochemicalmarketrs_325.htmGoogle Scholar
  3. 3.
    Gupta A. Osteoporosis in India—the nutritional hypothesis. Natl Med J Ind 1996; 9(6): 268–74Google Scholar
  4. 4.
    Facts and statistics about osteoporosis and its impact. International osteoporosis Foundation Osteoporosis society of India, 2003 Action plan osteoporosis. Consensus statement of an expert group, New Delhi. http://www.osteofound.org/press_centre/fact_sheet.htmlGoogle Scholar
  5. 5.
    Osteoporosis in postmenopausal women: Diagnosis and Monitoring. Summary, Evidence Report/Technology Assessment: No. 28. Agency for Healthcare Research and Quality Publication No. 01-E031, Feb 2001. http://www.ahrq.gov/clinic/epcsums/osteosum.htmGoogle Scholar
  6. 6.
    Susan A. Calcium Supplementation in Postmenopausal Women. From Medscape Ob/Gyn & Women's health, 2003: 8(2) http://www.medscape.com/viewarticle/460438Google Scholar
  7. 7.
    Delmas PD. Biochemical markers of bone turnover for the clinical investigation of osteoporosis. Osteoporos Int 1993; 3(1): 81–6PubMedCrossRefGoogle Scholar
  8. 8.
    Woitge HW, Nave CS, Kissing C, Bruckner GL, Meyer K, Grauer A, et al. Seasonal Variation of Biochemical Indexes of Bone Turnover; Results of a population-based Study. J Clin Endocrinol Metab 1998; 92(1): 68–75CrossRefGoogle Scholar
  9. 9.
    Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The Use of Biochemical Markers of Bone Turnover in Osteoporosis. Osteoporos Int 2000: Suppl 6: 2–17CrossRefGoogle Scholar
  10. 10.
    Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999; 45(8): 1359–68PubMedGoogle Scholar
  11. 11.
    Kleerekoper M. Biochemical markers of Bone Turnover: Why Theory, Research, and Clinical practice Are Still in Conflict. Clin Chem 2001: 47: 1347–9PubMedGoogle Scholar
  12. 12.
    Gotfredsen A, Westergren HH, Andersen T. Influence of orlistat on bone turnover and body composition. Int J Obes Relat Metab Disord 2001: 25, 1154–60PubMedCrossRefGoogle Scholar
  13. 13.
    Gitelman HJ. An Improved automatic procedure for the determination of Calcium in biologic specimens. Anal Biochem 1967: 18: 521–31CrossRefGoogle Scholar
  14. 14.
    Isselbacher KJ, Braunwad E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's Principles of Internal Medicine, 13th Ed. Vol 2, Mc Graw-Hill publication, 1994, 2139 ppGoogle Scholar
  15. 15.
    Daly JA, Ertingshausen G. Direct Method for Determining Inorganic Phosphate in Serum with the “CentrifiChem”, Clin Chem 1972: 18(3): 263–5PubMedGoogle Scholar
  16. 16.
    McMurray JR, Plasma Proteins. In Gowenlock AH, editor. Varley's Practical clinical Biochemistry, 6th ed, CBS publishers (Indian Reprint), New Delhi, 2002, 407–8Google Scholar
  17. 17.
    Varley H, editor. The Plasma Proteins: In Practical clinical Biochemistry, 4th ed, CBS publishers (Indian Edition), New Delhi, 1988, 243–4Google Scholar
  18. 18.
    Henry RJ, editor, Enzymes: In Clinical Chemistry Principle and techniques, Harper and Row publishers, New York, 1974, 815ppGoogle Scholar
  19. 19.
    Mitoma C, Smith TE, Davidson JD, Udenfriend S, Dacosta FM, Sjoerdsma, Bethesda. Improvements in methods for Measuring hydroxyproline. J Lab Clin Med 1959: 53(6): 970–6PubMedGoogle Scholar
  20. 20.
    Varley, H, editor. Non Protein Nitrogen: In Practical clinical Biochemistry, 4th ed, CBS publishers (Indian Edition), New Delhi, 1988, 197–8Google Scholar
  21. 21.
    Justesen TI, Petersen JLA, Ekbom P, Damm P, Matheisen ER. Albumin-to-Creatinine ratio in random urine samples might replace 24-h urine collections in screening for Micro-and Macroalbuminuria in pregnant women with Type-1 Diabetes. Diabetes Care 2006: 29(4): 924–5PubMedCrossRefGoogle Scholar
  22. 22.
    George BO. Urinary and Anthropometrical Indices of Bone Density in healthy Nigerian Adults. J Appl Sci Environ Mgt 2003: 7(1): 19–23Google Scholar
  23. 23.
    Lofman O, Magnusson P, Toss G, Larsson L. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Clin Chim Acta 2005: 356: 67–75PubMedCrossRefGoogle Scholar
  24. 24.
    Sachdeva A, Seth S, Khosla AH, Sachdeva S. Study of some common Biochemical bone turnover markers in post menopausal women. Ind J Clin Biochem 2005: 20(1): 131–4CrossRefGoogle Scholar
  25. 25.
    Rosen CJ, Tenenhouse A. Biochemical markers of bone turnover. Postgraduate Medicine 1998: 104(4): 101–18PubMedCrossRefGoogle Scholar
  26. 26.
    Mazzuoli G, Acca M, Pisani D, Diacinti D, Scarda A, Scarnecchia L, et al. Annual skeletal blance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study. Bone 2000: 26(4): 381–6PubMedCrossRefGoogle Scholar
  27. 27.
    De Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P, Caradonna P. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for toxic goiter. Clin Endocrinol 1997: 47(5): 529–35.CrossRefGoogle Scholar

Copyright information

© Association of Clinical BIochemists of India 2007

Authors and Affiliations

  • Indumati V. 
    • 2
  • Vidya S. Patil
    • 1
  • Rama Jailkhani
    • 1
  1. 1.Department of BiochemistryS.D.M College of Medical Sciences and HospitalDharwad
  2. 2.Department of Biochemistry, Belgaum Institute of Medical SciencesCivil HospitalBelgaum

Personalised recommendations